Objective Recent clinical trials suggest that antenatal exposure to magnesium sulfate (MG)
reduces the risk of adverse neurological outcomes in ex-preterm children. About 70% of …

Prevention of neurologic disability associated with preterm birth is one of the major
challenges in current perinatal medicine. Magnesium sulfate (MgSO4), the focus of this …

Introduction Preterm infants are at great risk of neurological impairments. This study aimed
to evaluate what is the difference in short-and long-term neonatal outcome comparing …

Antenatal magnesium sulphate reduces the risk of cerebral palsy in babies born< 30 weeks'
gestation. A guideline for its use in women at imminent risk of preterm birth was …

Objective Maternal exposure to magnesium sulphate has a neuroprotective effect in
premature infants. This study aimed to examine this neuroprotective effect and the dose …

Some observational studies show that, in very preterm births, magnesium sulfate treatment
is associated with a lower risk of intraventricular hemorrhage (IVH), which predisposes to …

Introduction The risk for brain injury manifested as cerebral palsy is higher in very preterm
born children than in term. Prenatal administration of magnesium sulfate (MgSO4) has been …

Antenatal magnesium sulfate and neuroprotection : Current Opinion in Pediatrics Antenatal
magnesium sulfate and neuroprotection : Current Opinion in Pediatrics Log in or Register …

Cerebral palsy (CP) remains the most significant neurological disorder associated with
preterm birth. It disrupts quality of life and places huge cost burdens on society. Antenatal …

Objective To evaluate whether magnesium sulphate (MgSO4) given to women at risk of very‐
preterm birth would be neuroprotective in preterm newborns and would prevent neonatal …